Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Athena
Athena Kalyvas, Laval CA
| Patent application number | Description | Published |
|---|---|---|
| 20100048727 | PERFLUOROKETONE COMPOUNDS AND USES THEREOF - Novel perfluoroketone compounds of formula [I] and [Ia] are described. Also described are uses thereof, such as for inhibition of phospholipase A | 02-25-2010 |
| 20110105610 | Phospholipase A2 Inhibitors and their Use in Treating Neurological Injury and Disease - Phospholipase A | 05-05-2011 |
Athena Kasvikis, Cincinnati, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100112022 | Antiperspirant Products and Methods of Merchandising the Same - A method of merchandising an antiperspirant product, comprising the steps of offering a solid or cream antiperspirant product for sale, wherein the antiperspirant product is a water-in-oil emulsion comprising 5% or more of water and one or more plant-derived materials in the continuous oil phase and communicating to perspective buyers that the antiperspirant product is natural and/or provides an environmental benefit. | 05-06-2010 |
Athena Menoudakos, Garden City, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080255614 | Teething holder - A teething holder for use with a child's teething item, and more particularly a teething device having a flexible and elastic loop, a lock for releaseably locking the loop around a teething object, such as a biscuit, and an attachment element, for attaching the teething device, such as to a baby's bib or chair. | 10-16-2008 |
| 20100170023 | WAIST BIB - A bib having an apron, a pocket, a waist strap, and a hip strap. The bib is especially useful for young children who may be uncomfortable wearing neck-type bibs. | 07-08-2010 |
Athena Spanoyannis, Ashburn, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20100273985 | POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 10-28-2010 |
| 20100273986 | POST-TRANSLATIONAL MODIFICATION AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 10-28-2010 |
| 20110046356 | POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 02-24-2011 |